Name: | Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione,6,16,18,20-tetrahydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-,(9S,12E,14S,15S,16S,17R,18R,19R,20S,21S,22E,24Z)- |
InChI: | InChI=1/C44H60N4O10/c1-11-23(4)48-18-16-44(17-19-48)46-32-29-30-38(52)27(8)40-31(29)41(54)43(9,58-40)57-20-15-28(56-10)24(5)36(50)26(7)37(51)25(6)35(49)21(2)13-12-14-22(3)42(55)45-34(39(30)53)33(32)47-44/h12-15,20-21,23-26,28,35-37,47,49-52H,11,16-19H2,1-10H3,(H,45,55)/b13-12+,20-15+,22-14-/t21-,23?,24+,25+,26-,28-,35-,36+,37?,43-/m0/s1 |
Specification: |
25-O-Deacetyl Rifabutin (CAS NO.100324-63-8), its Synonyms are 25-Desacetylrifabutin ; 25-O-Deacetyl-1',4-didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxorifamycin XIV ; Rifamycin XIV, 25-O-deacetyl-1',4-didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxo- ; Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione,6,16,18,20-tetrahydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-,(9S,12E,14S,15S,16S,17R,18R,19R,20S,21S,22E,24Z)- .
Unchanged drug, 25-O-Deacetyl Rifabutin and four other metabolites were identifed in human urine. The main urinary metabolite was 25-O-Deacetyl Rfabutin , other metabolites were characterized as oxidized, and oxidized-deacetylated derivatives. It was detected only in rat and man.
|